<SEC-DOCUMENT>0001477932-25-000373.txt : 20250122
<SEC-HEADER>0001477932-25-000373.hdr.sgml : 20250122
<ACCEPTANCE-DATETIME>20250122080013
ACCESSION NUMBER:		0001477932-25-000373
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241231
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250122
DATE AS OF CHANGE:		20250122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Health Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41308
		FILM NUMBER:		25543927

	BUSINESS ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		5 AGIOU GEORGIOU, PILEA
		CITY:			THESSALONIKI
		STATE:			J3
		ZIP:			55438

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cosmos Holdings Inc.
		DATE OF NAME CHANGE:	20140106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cosm_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:cosm="http://cosm.com/20241231"><head><title>cosm_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:left;font:10pt times new roman"><div style="display:none;text-align:left;font:10pt times new roman;margin:0px 7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2024-12-31to2024-12-31" id="ixv-297">0001474167</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2024-12-31to2024-12-31" format="ixt:booleanfalse" id="ixv-298">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cosm-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="From2024-12-31to2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>WASHINGTON, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM&#160;<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:DocumentType" id="ixv-318">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (Date of earliest event reported)&#160;<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen" id="ixv-319">December 31, 2024</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:74%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityRegistrantName" id="ixv-320">COSMOS HEALTH INC.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td style="width:74%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="ixv-321">Nevada</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityFileNumber" id="ixv-322">000-54436</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityTaxIdentificationNumber" id="ixv-323">27-0611758</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(State or other jurisdiction</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">of incorporation)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Commission</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">File Number)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(I.R.S. Employer</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Identification No.)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityAddressAddressLine1" id="ixv-324">5 Agiou Georgiou</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityAddressAddressLine2" id="ixv-325">Pilea</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityAddressCityOrTown" id="ixv-326">Thessaloniki</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="ixv-327">Greece</ix:nonNumeric></strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityAddressPostalZipCode" id="ixv-328">55438</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Address of principal executive offices)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Zip Code)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Registrant&#8217;s telephone number, including area code&#160;<strong><span style="text-decoration:underline">(<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:CityAreaCode" id="ixv-329">312</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:LocalPhoneNumber" id="ixv-330">865-0026</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">N/A</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address, if changed since last report.)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Title of Each Class</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Trading</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Symbol</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Name of Each Exchange</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>On Which Registered</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:Security12bTitle" id="ixv-331">Common Stock, $.001 par value</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:TradingSymbol" id="ixv-332">COSM</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-333">Nasdaq</ix:nonNumeric>&#160;Capital Market</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="ixv-334">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="ixv-335">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="ixv-336">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="ixv-337">&#9744;</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b of this chapter).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Emerging growth company&#160;<ix:nonNumeric contextRef="From2024-12-31to2024-12-31" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-338">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Item 1.01 Entry into a Definitive Agreement </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On December 31, 2024 (&#8220;Effective Date&#8221;), Cosmos Health Inc. (&#8220;the Company&#8221;) and DocPharma Single SA. (Greece) a related party (hereinafter &#8220;Licensor&#8221;), entered into a Patent and Technology License Agreement whereby Licensor granted the Company a royalty-bearing, exclusive worldwide license to actively commercialize at least one of two patents for treatment of cancer through research and preclinical and clinical trials (including CDA, clinical studies Phase I, II, III) for the life of the patents or 20 years, whichever is longer.&#160; Patent #1 was filed in 2016 and Patent #2 was filed in 2017.&#160; The Company was granted the right to sublicense.&#160; The Company has an optional buy-out right for the total amount of EUR 7,500,000, constituting EUR 4,000,000 for Patent 1 and EUR 3,500,000 for Patent 2 exercisable throughout the term subject to 60 day notice and a 60 day close.&#160; The Company will pay Licensor a running royalty consisting of:&#160; an initial payment of $500,000 to be paid by year end of 2024; for the five year term of 2025 to 2030, a fixed amount of EUR 350,000 per annum (the &#8220;<span style="text-decoration:underline">Start-Up Term</span>&#8221;); and after the Start-Up Term, one and a half percent (1,5%) of annual Net Sales for Licensed Products covered by an issued patent.&#160; All payments during the Start-Up Term are payable annually within 30 days of year end, and thereafter within 30 days of finalization of financial statements.&#160; Any time after the 5<sup style="vertical-align:super">th</sup> year of the Effective Date. The Company has the right to terminate for convenience subject to 30 day notice.&#160; Licensor may terminate for breach or default by the Company if not cured within 60 days or upon the Company&#8217;s bankruptcy, insolvency or receivership.&#160; The Agreement is governed by New York law and is subject to New York courts. &#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Item 9.01 Financial Statements and Exhibits </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(d) Exhibits </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:8%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="cosm_ex101.htm">10.1</a></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="cosm_ex101.htm">Patent and Technology License Agreement</a></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">104</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">-2-</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td/><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>COSMOS HEALTH INC.</strong></p></td><td/></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:12%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Date: January 22, 2025</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">By:</p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>/s/ Georgios Terzis</em></p></td><td/></tr><tr style="height:15px"><td/><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Georgios Terzis</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td/><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Chief Financial Officer</p></td><td/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">-3-</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cosm_ex101.htm
<DESCRIPTION>PATENT AND TECHNOLOGY LICENSE AGREEMENT
<TEXT>
<html><head><title>cosm_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>&nbsp; EXHIBIT 10.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>PATENT AND TECHNOLOGY LICENSE AGREEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This Patent and Technology License Agreement ("<u>Agreement</u>") is made on December 31, 2024 (the &#8220;<u>Effective Date</u>&#8221;) by and between DOCPHARMA Single SA. (&#8220;<u>Licensor</u>&#8221;), a Greek company, located at Agiou Georgiou 5, 57001, Pylaia, Greece, and COSMOS HEALTH INC., a Nevada corporation, located at 141 West Jackson Boulevard, Suite 4236, Chicago IL 60604 ("<u>Licensee</u>").</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">WHEREAS:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Inventions and Patent Rights (both as defined below) are owned by Licensor.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">B.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Parties desire to jointly exploit the Inventions and agree that to this end, it is prudent for Licensee to secure Licensor&#8217;s rights in Inventions and Patent Rights by license to use, develop, manufacture, market, and commercialize the Patent Rights.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">NOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties agree as follows:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>I. DEFINITIONS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">As used in this Agreement, the following terms have the following meanings:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.1</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Actively Commercialize</u>&#8221; means being engaged in an ongoing and active program directed towards Sale of Licensed Products that is reasonably funded in light of the research, development, manufacturing, regulatory, marketing or sales efforts required to make the Licensed Products available to the commercial market.</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.2</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Affiliate</u>&#8221; means any business entity more than fifty percent (50%) owned by Licensee, any business entity which owns more than fifty percent (50%) of Licensee, or any business entity that is more than fifty percent (50%) owned by a business entity that owns more than fifty percent (50%) of Licensee.</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.3</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Inventions</u>&#8221;<strong> </strong>means all discoveries and inventions described in part by the Patent Rights included in <u>Exhibit 1</u> to the Agreement.</p></td></tr> <tr style="height:15px"> <td></td> <td></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.4</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Licensed Field</u>&#8221;<strong> </strong>means treatment of cancer for human use.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.5</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Licensed Products</u>&#8221;<strong> </strong>means any pharmaceutical drugs or products sold by Licensee, any Affiliate or its sublicensees comprising Licensed Subject Matter pursuant to this Agreement.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.6</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Licensed Subject Matter</u>&#8221; means the Patent Rights, Technology Rights and Inventions.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.7</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Licensed Territory</u>&#8221;<strong> </strong>means worldwide.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.8</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Net Sales</u><strong>&#8221; </strong>means the gross revenues received by Licensee, its Affiliate, or its sublicensees from a Sale less sales discounts actually granted, sales and/or use taxes actually paid, import and/or export duties actually paid, outbound transportation actually prepaid or allowed, and amounts actually allowed or credited due to returns (not exceeding the original billing or invoice amount), all as recorded by Licensee in Licensee&#8217;s official books and records in accordance with generally accepted accounting practice and consistent with Licensee&#8217;s published financial statements and/or regulatory filings with the United States Securities and Exchange Commission. In the event of a Sale of a Combination Product, the parties shall work together in good faith to determine what portion of resulting gross revenues shall be used for determining Net Sales based on the value added to the price such Combination Product by Licensed Subject Matter relative to value added by other active ingredients or other proprietary technology or information. For purpose of this Section 1.8, the term &#8220;Combination Product&#8221; means any Licensed Products that contain at least one other active ingredient.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.9</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Patent Rights</u><strong>&#8221; </strong>means Licensor's rights in (a) Inventions covered in patents and/or patent applications, whether domestic or foreign, which identify Licensor as holder, applicant or owner, including the two patents listed in <u>Exhibit 1</u> to this Agreement as Patent 1 and Patent 2; (b) all non-provisional patent applications that claim priority to any provisional application relating to the Inventions; and (c) all divisionals, continuations, and such claims of continuations-in-part as are entitled to claim priority to the aforesaid patent and/or patent applications, and all reissues, reexaminations, extensions of, and foreign counterparts; and (d) any patents that issue with respect to the aforesaid patent applications.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.10</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Sale</u><strong>&#8221; </strong>or &#8220;<u>Sold</u>&#8221;<strong> </strong>means the transfer or disposition of any Licensed Products for value to a party other than Licensee or an Affiliate.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">1.11</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;<u>Technology Rights</u><strong>&#8221; </strong>means Licensor's rights in any technical information, processes, procedures, compositions, devices, methods, formulae, protocols, techniques, software, designs, drawings or data related to the Inventions and created by the inventor(s) listed in Exhibit 1 before the Effective Date, whether or not they are claimed in Patent Rights but that are necessary for exercising Patent Rights.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>II. LICENSE</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">2.1</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensor hereby grants to Licensee a royalty-bearing, exclusive license under the Patent Rights and Technology Rights, to develop, manufacture, have manufactured, use,<em> </em>import, offer to sell and/or sell Licensed Products within the Licensed Territory for use within the Licensed Field. This grant is subject to the payment by Licensee to Licensor of all consideration as provided herein, and includes rights of Licensee to:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Publish the general scientific findings from research related to the Licensed Subject Matter, subject to the terms of Article X; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Use Inventions covered by Patent Rights for research, patient care, and all use of Inventions covered by Patent Rights in preclinical and clinical trials (including CDA, clinical studies Phase I, II, III) and other research involving patients or otherwise as required by applicable regulations.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">2.2 </font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee may extend the license granted herein or assign this Agreement to any Affiliate provided that the Affiliate consents in writing to be bound by this Agreement to the same extent as Licensee. Licensee agrees to deliver such contract to Licensor within thirty (30) calendar days following execution thereof.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">2.3</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee may grant sublicenses under Licensed Subject Matter consistent with the terms of this Agreement provided that Licensee is responsible for its sublicensees relevant to this Agreement, and for diligently collecting all amounts due Licensee from sublicensees. If a sublicensee pursuant hereto becomes bankrupt, insolvent or is placed in the hands of a receiver or trustee, Licensee, to the extent allowed under applicable law and in a timely manner, agrees to use reasonable commercial efforts to collect all consideration owed to Licensee and to have the sublicense agreement confirmed or rejected by a court of proper jurisdiction. A sublicense agreement shall not exceed the scope and rights granted to Licensee hereunder.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">2.4</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If this Agreement is terminated pursuant to Article XI, and if Licensee does not exercise its Buy-Out Right under Article III, Licensor agrees to accept as successors to Licensee, existing sublicensees in good standing at the date of termination provided that each such sublicensee consents in writing to be bound by all of the terms and conditions of this Agreement.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>III. BUY-OUT RIGHT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">3.1</font></p></td> <td style="MARGIN: 0px;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensor hereby grants to Licensee for the Term of this Agreement the rights to purchase and acquire at any time any Patent Rights and Technology Rights licensed hereunder for the total amount of EUR 7,500,000, constituting EUR 4,000,000 for Patent 1 and EUR 3,500,000 for Patent 2 as described in <u>Exhibit 1</u> hereto (the &#8220;<u>Buy-Out Right</u>&#8221;). Licensee may exercise its Buy-Out Right by 60 day prior written notice sent to Licensor, with the parties to close on the purchase by the expiry of such 60 days unless otherwise mutually agreed in writing.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>IV. CONSIDERATION, PAYMENTS AND REPORTS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">4.1</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In consideration for the rights granted by Licensor to Licensee under this Agreement, Licensee by itself or through any of its Affiliates and sublicensees will use reasonable commercial efforts to Actively Commercialize at least one of Patent 1 or Patent 2 in the Licensed Field in the Licensed Territory prior to expiration of the Patent Rights.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">4.2</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;Additionally and subject to Article III, in consideration for the rights granted by Licensor to Licensee under this Agreement, Licensee also agrees to pay Licensor a running royalty (&#8220;<u>Royalty</u>&#8221;) as follows:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.5in; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">an initial payment of $500,000 to be paid by year end of 2024;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2) </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">for the five year term of 2025 to 2030, a fixed amount of EUR 350,000 per annum (the &#8220;<u>Start-Up Term</u>&#8221;); and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">after the Start-Up Term, one and a half percent (1,5%) of annual Net Sales for Licensed Products covered by an issued patent.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">If Licensee is obligated to pay running royalties to a third party to avoid infringing such third party&#8217;s patent rights which dominate Licensor&#8217;s Patent Rights (as documented by a written opinion of an independent, qualified patent attorney, a copy of which shall be provided to Licensor), Licensee may reduce the running royalty due Licensor in any given year by the amount of the running royalty rate being paid to such third party.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">4.3</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Unless otherwise provided, all payments during the Start-Up Term are payable annually within thirty (30) days of the end of the calendar year and all payments thereafter after finalization of the financial statements for the year ended December 31 of each year during the term of this Agreement, at which time Licensee will also deliver to Licensor a true and accurate report, giving such particulars of the business conducted by Licensee, any Affiliate and its sublicensees, if any exist, during the preceding twelve (12) calendar months under this Agreement as necessary for Licensor to account for Licensee's payments hereunder. This report will include pertinent data, including, but not limited to:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(a)</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the accounting methodologies used to account for and calculate the items included in the report and any differences in such accounting methodologies used by Licensee, any Affiliate and any sublicensees since the previous report; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a list of Licensed Products under preclinical development or produced by Licensee, any Affiliate and sublicensees for the twelve (12) preceding calendar months; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(c)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the total quantities of Licensed Products produced by Licensee, any Affiliate and sublicensees; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the total Net Sales by Licensee, any Affiliate and sublicensees; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(e)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the calculation of Net Sales; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(f)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the royalties so computed and due Licensor and/or minimum and royalties; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(g)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">all consideration received from each sublicensee or assignee and payments due Licensor; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(h)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">all other amounts due Licensor herein; and</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(i)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a progress report as to Licensee&#8217;s and any Affiliate and sublicensees&#8217; efforts and accomplishments during the preceding year to Actively Commercialize Licensed Subject Matter in the Licensed Territory and Licensee's and sublicensees' commercialization plans for the upcoming year.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Simultaneously with the delivery of each such report, Licensee agrees to pay Licensor the amount due; if any, for the period of such report. These reports are required even if no payments are due.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">4.4</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the term of this Agreement and for one (1) year thereafter, Licensee agrees to keep complete and accurate records of its, any Affiliate and its sublicensees&#8217; Net Sales in sufficient detail to enable the royalties and other payments due hereunder to be determined. Licensee agrees to permit Licensor or its representatives, at Licensor's expense, to periodically examine upon reasonable notice Licensee's books, ledgers, and records during regular business hours for the purpose of and to the extent to necessary to verify any report required under this Agreement. If any amounts due Licensor are determined to have been underpaid in an amount equal to or greater than five percent (5%) of the total amount due during the period so examined, then Licensee will pay the cost of the examination plus accrued interest at the lesser of: (1) highest allowable rate: or (2) the prime rate plus two percent.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><font style="font-family:symbol">4.5</font></p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">All amounts payable hereunder by Licensee will be paid without deductions for taxes, assessments, fees, or charges or any kind unless required by the laws of the jurisdiction where sales are made. In the event that the laws of the jurisdiction in which sales are made limit the repatriation of funds, Licensee shall use commercially reasonable efforts to repatriate all funds owing to Licensor, and shall, in all cases, repatriate funds owed to Licensor in equal proportion to any amounts belonging to Licensee which are repatriated from such jurisdiction.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>V. PATENT PROTECTION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">5.1</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee is responsible for preparing, filing, prosecuting, defending, and maintaining Patent Rights to the Inventions made in the name of both parties and will consult with and keep Licensor fully informed of Patent Rights status. Licensee will copy Licensor on patent related communications filed with the United States Patent and Trademark Office and any other patent office where patent applications related to the Inventions and Patent Rights are filed and/or pending, including, but not limited to, patent applications, modifications and amendments, office actions, and responses. The parties each have the right to review and comment upon the wording of specifications, claims, and responses to office actions prior to their submission to the appropriate patent office, in the event of a disagreement as to wording, the Parties agree to work with each other to resolve any disagreements. Patent Rights will not be abandoned without the written consent of Licensor.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">5.2</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensor will use its best efforts to ensure that any Inventors fully cooperate in the preparation, filing, prosecution and maintenance of Patent Rights.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>VI. INFRINGEMENT BY THIRD PARTIES</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">6.1</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee must notify Licensor in writing of any potential infringement of Patent rights by third parties within thirty (30) calendar days of knowledge thereof. If Licensee, with Licensor&#8217;s consent, does not amicably resolve the dispute within three (3) months of knowledge thereof, then Licensor may, at its sole discretion, enforce any Patent Rights licensed hereunder on behalf of itself and Licensee, with Licensor retaining all proceeds of any award and/or damages. Licensor shall not settle any such action upon terms which render the license granted pursuant to this Agreement non-exclusive or would otherwise be incompatible with the terms of this Agreement without the written consent of Licensee.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">6.2</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In any suit or dispute involving an infringer, the parties agree to cooperate fully with each other. At the request and expense of the party bringing suit, the other party will permit access during regular business hours, to all relevant personnel, records, papers, information, samples, specimens, and the like in its possession.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>VII. PATENT MARKING</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">7.1</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Licensee agrees that all Licensed Products, and associated material such as documentation and packaging, sold by Licensee, any Affiliate, and/or sublicensees of Licensee, will be permanently and legibly marked with the number of any applicable patents licensed hereunder in accordance with each relevant country's patent laws, including Title 35, United States Code.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>VIII. INDEMNIFICATION AND INSURANCE</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">8.1 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee agrees to hold harmless and indemnify Licensor, its owners, directors, officers, and employees ("<u>Licensor Indemnitees</u>") from and against any claims, demands, or causes of action whatsoever, costs suit and reasonable attorney's fees, including without limitation, those costs arising on account of any injury or death of persons or damage to property caused by; or arising out of, or resulting from, the exercise or practice of the rights granted hereunder by Licensee, its officers, any Affiliate or its officers, employees, agents or representatives. In any action brought by a third party against Licensor Indemnitees for an indemnified claim, subject to applicable law, Licensee shall control the defense of such action and shall be responsible for selection of counsel and all aspects of the action. With Licensor's consent, which will not unreasonably be withheld or delayed, Licensee shall have the right to settle any such claim with the third-party claimant in any manner which would not impose monetary liability on Licensor not reimbursed by Licensee's indemnity obligations, or which would require an explicit admission of culpability by Licensor. The parties understand and agree that the limitation of damages in Section 8.2 shall not apply to any claim under this section.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">8.2</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Except for indemnified claims under section 8.1 above, in no event shall either party be liable for any indirect, special, consequential or punitive damages (including, without limitation, damages for loss of profits or expected savings or other economic losses, or for injury to persons or property) arising out of, or in connection with, this Agreement or its subject matter, regardless of whether that party knows or should know of the possibility or such damages.</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">8.3</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Beginning at the time when any Licensed Subject Matter is being distributed or sold for human use (including for purpose of obtaining regulatory approvals) by Licensee, an Affiliate, or by a sublicensee, Licensee shall, at its sole cost and expense, procure and maintain commercial general liability insurance and Licensee shall use reasonable efforts to have Licensor named as an additional insured. Such commercial general liability insurance shall provide: (i) product liability coverage (ii) coverage for contractual liability and (iii) coverage for litigation costs. Prior to the time when any Licensed Subject Matter is being distributed or sold for human use, Licensee shall purchase such insurance as it deems necessary for Licensee's purposes, provided, however, that in connection with any commercial general liability insurance policy acquired by Licensee, Licensee shall use reasonable efforts to have Licensor named as an additional insured on such policy.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">8.4</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee shall provide Licensor with written evidence of such insurance within thirty (30) calendar days of its procurement. Additionally, Licensee shall provide Licensor with written notice at least fifteen (15) calendar days prior to the cancellation, non-renewal or material change in such insurance.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">8.5</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee shall maintain such commercial general liability insurance beyond the expiration or termination of this Agreement during the period that any Licensed Subject Matter developed pursuant to this Agreement is being commercially distributed sold by Licensee, an Affiliate or by a sublicensee or agent of Licensee.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>IX. USE OF NAME</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">9.1</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee will not use the name of (or the name of any employee of) Licensor in any advertising, promotional or sales literature, on its Website, without the advance express written consent of Licensor. Such permission will not be unreasonably withheld. Notwithstanding the forgoing, Licensee may disclose the existence of this Agreement and the fact that Licensor is the licensor under this Agreement for the purposes of raising capital, and Licensee may use the name of (or name of an employee of) Licensor in routine business correspondence or as needed in appropriate regulatory submissions without express written consent.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>X. CONFIDENTIAL INFORMATION AND PUBLICATION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">10.1</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subject to Licensee's rights in Section 10.2 below, Licensor and Licensee each agree that all information contained in documents marked &#8220;confidential&#8221; and forwarded to by the other (i) are to be received in strict confidence, (ii) will be used only for the purposes of this Agreement, and (iii) will not be disclosed by the recipient party (except as required by law, regulation or court order), its agents or employees without the prior written consent of the disclosing party, except to the extent that the recipient party can establish by competent written proof that such information:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(a)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">was in the public domain at the time of disclosure; or</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(b)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">later became of the public domain through no act or omission of the recipient party, its employees, agents, successors or assigns: or</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(c)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">was lawfully disclosed to the recipient party by a third party having the right to disclose it; or</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(d)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">was already known by the recipient party at the time of disclosure; or</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(e)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">was independently developed by the recipient party without use of the disclosing party's confidential information; or</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(f)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">is required by law or regulation to be disclosed, provided that the disclosing party gives adequate advance notice to the other of such disclosure to allow that party to assert whatever exclusion or exception may be available to it under such law or regulation; or</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(g)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">was not marked as Confidential or, if disclosed orally, was reduced to writing and marked Confidential within thirty (30) days of disclosure.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">10.2</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Each party's obligation of confidence hereunder will be fulfilled by using at least the same degree of care with the disclosing party's confidential information as it uses to protect its own confidential information, but always at least a reasonable degree of care. This obligation will exist while this Agreement is in force and for a period of three (3) years thereafter, except for confidential information which may be protected by law or regulation, in which case, such information shall be protected as long as mandated by such law or regulation requires. Licensee shall have the right to disclose confidential information which is licensed as part of this Agreement as is reasonably required in the development and commercialization of Licensed Products so long as such disclosures do not have an adverse effect on the Patent Rights.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">10.3</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensor and Licensee shall have the right to publish the general scientific findings from research related to Licensed Subject Matter, with due regard for the protection of each party's confidential information, the protection of current and future patent filing opportunities, regulatory and development concerns and other reasonable considerations relating to the development of Licensed Products pursuant to this Agreement. The party desiring to publish will submit the manuscript of any proposed publication to the other party at least forty-five (45) calendar days before such manuscript is submitted for consideration by any publication, and the reviewing party shall have the right to review and comment upon the publication in order to protect its confidential information. Upon the reviewing party's request, publication may be delayed up to sixty (60) additional calendar days to enable the reviewing party to secure adequate intellectual property protection of its confidential information that would otherwise be the publication. In the event that the parties reasonably determine that additional research or development work is required or ongoing research and development needs to be completed in order to secure appropriate intellectual property protection, and that publication will be detrimental to obtaining adequate intellectual protection, then, at the reviewing party's request and immediate funding of said additional research and development work, the party desiring to publish shall delay such publication until completion of the research or development work and filing of appropriate patents based upon such work.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>XI.</strong> <strong>TERM AND TERMINATION</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">11.1 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subject to Sections 11.3 and 11.4 herein, the term of this Agreement is from the Effective Date to the full end of the term or terms for which Patent Rights have not expired, or for a term of twenty (20) years, whichever is longer (the &#8220;<u>Term</u>&#8221;).</p></td></tr> <tr style="height:15px"> <td style="MARGIN: 0px;"> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">11.2</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Any time after the fifth (5th) anniversary of the Effective Date, Licensee has the right to terminate this Agreement for convenience subject to thirty (30) days prior written notice to Licensor.</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">11.3</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Subject to any rights herein which survive termination, this Agreement will earlier terminate in its entirety:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(a)</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">automatically, if Licensee becomes bankrupt or insolvent and/or if the business of Licensee shall be placed in the hands of a receiver, assignee, or trustee, whether by voluntary act Licensee or otherwise; or</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">upon sixty (60) calendars days written notice from Licensor if Licensee breaches or default on any obligation under this Agreement, unless, before the end of the such sixty (60) calendar-day notice period, Licensee has cured the default or breach to Licensor's reasonable satisfaction and so notifies Licensor, stating the manner of the cure; or</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">11.4</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Upon termination of Agreement:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">nothing herein will be construed to release either party of any obligation maturing prior to the effective date of the termination; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee covenants and agrees to be bound by the provisions of Articles VIII, IX and X of this Agreement; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(c)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee may, for a period of one year after the effective date of the termination, sell all Licensed Products therefore that it has on hand at of termination, if Licensee pays the earned Royalty thereon and any other amounts due pursuant to Article IV of this Agreement; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subject to Section 11.4(c), Licensee agrees to cease and desist any use and all Sale of the Licensed Subject Matter and Licensed Products upon termination of this Agreement.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>XII. LICENSOR </strong><strong>REPRESENTATION AND WARRANTY</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">12.1</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensor represents and warrants that (a) it is the sole and exclusive owner and holder of all rights, title, and interest in and to the Patent Rights, Technology Rights and Licensed Subject Matter, (b) it has the right to grant licenses thereunder, (c) it has not granted licenses thereunder to any other entity that would restrict rights granted hereunder, (d) it does not know of any intellectual property belonging to Licensor which may require a separate license in order to commercialize the Patent Rights, Technology Rights, Licensed Products pursuant to this Agreement, (e) it has disclosed to Licensee all relevant Licensor information relating to the practice of the Patent Rights and Technology Rights and the Licensed Subject Matter and has not fabricated or withheld information from Licensee.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">12.2</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensee understands and agrees that other than as expressly set forth in 13.1 above, Licensor by this Agreement, makes no representation as to the operability or fitness for any use, safety, efficacy, approvability by regulatory authorities, time and cost of development, patentability, and/or breadth of the Patent Rights, Technology Rights or Licensed Subject Matter.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>XIII. GENERAL</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">13.1 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Entire Agreement.</u> This Agreement constitutes the entire and only agreement between the parties for Licensed Subject Matter and all other prior negotiations, representations, agreements and understandings are superseded hereby. No agreements altering or supplementing the terms hereof will be made except by a written document signed by both parties.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.2 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Notices</u>. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next business day if sent after normal business hours of the recipient or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this section):</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;"><u>If to Licensee to</u>:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Cosmos Health Inc. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">141 West Jackson Blvd.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Suite 4236</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Chicago, IL&nbsp; 56064</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Attn: Grigorios Siokas</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">e-mail: <u>greg.ceo@cosmoshealthinc.com&nbsp; </u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><u>with a copy to</u>:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Davidoff Hutcher &amp; Citron LLP</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">605 Third Avenue, 34<sup style="vertical-align:super">th</sup> Floor</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">New York, New York 10158</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Facsimile: 212-286-1884</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Email: <u>ehl@dhclegal.com</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Attn: Elliot Lutzker</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><u>If to Licensor to</u>: </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">DocPharma Single S.A. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Agiou Georgiou 5</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Pylaia, Thessaloniki 57001</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Greece</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Attn: Theodoros Siokas </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">Email: <u>director@docpharma.gr </u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;">or such other addresses as may be given from time to time under the terms this notice provision.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">13.3 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Compliance</u>. Licensee must comply with all applicable federal, state and local laws and regulations in connection with its activities pursuant to this Agreement.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.4 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Governing Law</u>. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, without giving effect to principles of conflicts of law or choice of law that would compel the application of the substantive laws of any other jurisdiction. The parties hereby consent to the concurrent exclusive jurisdiction of the courts of the State of New York and the United States located in New York County, New York in connection with any suit, action or proceeding arising out of or relating in any manner to this Agreement, and each of the parties further irrevocably agrees to waive any objection to the venue of any such suit or proceeding in either court, or to in personal jurisdiction.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.5 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>WAIVER OF TRIAL BY JURY</u>. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY LITIGATION, ACTION, PROCEEDING, CROSS-CLAIM, OR COUNTERCLAIM IN ANY COURT (WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF, RELATING TO OR IN CONNECTION WITH (I) THIS AGREEMENT OR THE VALIDITY, PERFORMANCE, INTERPRETATION, COLLECTION OR ENFORCEMENT HEREOF OR (II) THE ACTIONS OF THE PARTIES IN THE NEGOTIATION, AUTHORIZATION, EXECUTION, DELIVERY, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.6 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Validity</u>. If any part of this Agreement is for any reason found to be unenforceable, all other parts nevertheless will remain enforceable. </p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.7 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Expenses</u>. Except as otherwise expressly provided herein, all costs and expenses, including, without limitation, fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses. </p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.8 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Amendment and Modification; Waiver</u>. This Agreement may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.9 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Specific Performance</u>. The parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy to which they are entitled at law or in equity.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">13.10 </p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Counterparts</u>. This Agreement may be signed in counterparts, each of which shall be considered an original and together they shall constitute one agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:center;">[Signature Page Follows]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><strong>IN WITNESS</strong><strong> WHEREOF</strong>, the parties hereto have caused their duly authorized representative to execute this Agreement as of the Effective Date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">DOCPHARM Single SA.</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px">COSMOS HEALTH INC.</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="width:5%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:10%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:5%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Theodoros Siokas</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Grigorios Siokas</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Theodoros Siokas</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Grigorios Siokas</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">President and CEO</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Director and CEO</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Date:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">December 31, 2024</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Date:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">December 31, 2024</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cosm-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/21/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:cosm="http://cosm.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cosm.com/20241231">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://cosm.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
 <import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
 <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
 <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
 <import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
 <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
 <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
 <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cosm-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/21/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address Country</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>cosm-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/21/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://cosm.com/role/Cover" xlink:href="cosm-20241231.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://cosm.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cosm-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/21/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cosm.com/role/Cover" xlink:href="cosm-20241231.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cosm.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cosm-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 01/21/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://cosm.com/role/Cover" xlink:href="cosm-20241231.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://cosm.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46481929029120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COSMOS HEALTH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001474167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-0611758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">5 Agiou Georgiou<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Pilea<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Thessaloniki<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">55438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">865-0026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-54436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">GR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COSM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ !4 V6JK$(A8S 0  (@(
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  %0#9:99!YDAD!  #/ P  $P
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M@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (  5
M-EH'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N
M>&UL4$L! A0#%     @ !4 V6M#HW8CN    *P(  !$              ( !
MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ !4 V6IE<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  %0#9:3X4C.#@$  #Q$   &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ !4 V6I^@&_"Q @
MX@P   T              ( !>PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  %0#9:EXJ[',     3 @  "P              @ %7#P  7W)E;',O+G)E
M;'-02P$"% ,4    "  %0#9:JL0B%C,!   B @  #P              @ %
M$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ !4 V6B0>FZ*M    ^ $
M !H              ( !H!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ !4 V6F60>9(9 0  SP,  !,              ( !A1(
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  SQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="cosm_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cosm.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cosm-20241231.xsd</File>
    <File>cosm-20241231_cal.xml</File>
    <File>cosm-20241231_def.xml</File>
    <File>cosm-20241231_lab.xml</File>
    <File>cosm-20241231_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="cosm_8k.htm">cosm_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cosm_8k.htm": {
   "nsprefix": "cosm",
   "nsuri": "http://cosm.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "cosm-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "cosm-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cosm-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cosm-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cosm-20241231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "cosm_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://cosm.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-12-31to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cosm_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-12-31to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cosm_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001477932-25-000373-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-25-000373-xbrl.zip
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M9P* 0V^F#*MI)\ ?[;ZH;IZIW-^R.0 Y Q0_UY^.0L&#@7E8!7U";<'$(5J
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MGM;-!U@+#[8(/[WO#7K=L_T'V64S"0LBV8>[GL'7N1S!8C,_C=(L!#&LYS*
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MMU/^KG/X%I[S="IQ\!W1I__ZZ]0,^PJ<X,!P7GQ.L30><QEGN8BTXLB>R<A
M2#O[W/!8,G&R!N_;4SA<GPI8I,GDV5GA1QZW%M8^U]3.YHYHH76FT"):<%@B
M)(W'6ET&M&'3>RG^A,Z?>KS(1'5*F+*S/3B9'!,OW&]HJ) (A18O$!G X9Z1
M$@SC(/]0O7EL0LN9XE%2[,;E_GBF)-ZBV?J+P7S,3" (9APQ$!6SR9EC$3J'
MUW:WUN$@BF$&)'JS%MI+6%5?55"068427Z7CE9_X\?N)=UJ6.E79B^P+**%6
MVCA +D.*U%$]%;.EMINJ>[-$(6F*)6)#*,G'37 O,*#4>6,:@0MCBA"V.9AD
M2#41P Y"QRUFV:(3Q>"M$%+ENB4+S>]D4_01]N-]568OX.XC41%@S%R,9/(E
M*^8YQKWA:&?T4$9<%7#DVQQU):8P-LUH(H-T(]]QGL'D(]"MA+P926.%C,&#
M\=Q[6ETL+XPW!9K$=PT/"Z^90O"E#$)-UN4%5W)O;1HO1IQYCAI<.-1UQ5&6
MT&>745].$7?*;&QI,HZR&:/8,O4')S)3GF60%AG!JQ :! _T1Y%%.HP"!@)U
MF]MC%%2)>N.> VB 06FLB=N#PA\NOBR:N96T? K2LEUI@_TEL08?&)U'+AX_
MX<FY;?K&!^KY/,,4>Z;537$@14+O3;'8."F,G6FVOVVECX9BB<=QNYV1EZB8
M@,Z!$:8TJ_BYT:L-(AJ%846F6JBBSB4YK811F$)*]QJ[AT*14!7=2H)N0PJ.
M+RROH5[ACC:L!'Q(&&!HR/'!Y3/C8=,9'B3.U=\4;SY^WCCY.!3$,[D*=[4Q
MW+5[=;C+G^TVAKY07\)=.$1\[;*F1K0A?,#"72#2 G)6,6,)N9M06! 8 (9'
M?UPC.F:MN[ \H=U \C275E'# ?4^#L0OG;VMK<X6_$>R)8_R@H0*_O:<OH?_
MJ(4*9A!_WK6W^C_O,.6=E]*_A$@T>EZ-?;,BE7WB3,\"9$/V4E$.K^'%%IIW
MC/$C 0F#PA. 0-K&VK2OKE-JTQ9M3B!! DNS;NG>BH$UJ*_S*%O@W)%DYMY0
M?:?TB-)ER'Q:B-C'UQUZTOJ)"-MO"-C?-L7!R?%9_[ WZ")Q5D><=C\C9^T9
ML=H.>J<G@^%=LVD]<:E[_VKB\Y;!#_IU-CLKZ&IVBT>T61'0%G90-77=SW ;
MR!@5C\F<G&9I,9F2&(;M7\F>T@:5[.E]%Y$)=GS31&QFN:HE48Q+Z>N+VD;
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M0&6)7S;'$^Z50JV&E]O4&ZC+C$;I<#D<M\RN1Q>"CC+3K'TG=&P0"(P/0E@
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M,Y?\=,;V 34Z(E^FQXZWY"FOHM'+D-:/5NI9+<OO7)8W<\O<L#]/#E,Y62,
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MHS1<O/[_4$L! A0#%     @ !4 V6DQ@8'V<!   'A<  !$
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M4$L! A0#%     @ !4 V6MLN7(F(!   7"0  !4              ( !W \
M &-O<VTM,C R-#$R,S%?<')E+GAM;%!+ 0(4 Q0    (  5 -EHV'?:IT!
M "ED   +              "  9<4  !C;W-M7SAK+FAT;5!+ 0(4 Q0    (
M  5 -EK41?&SWS4  $>& 0 .              "  9 E  !C;W-M7V5X,3 Q
:+FAT;5!+!08     !P ' , !  ";6P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>cosm_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cosm-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-12-31to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001474167</identifier>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-12-31to2024-12-31" id="ixv-297">0001474167</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-12-31to2024-12-31" id="ixv-298">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2024-12-31to2024-12-31" id="ixv-318">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2024-12-31to2024-12-31" id="ixv-319">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2024-12-31to2024-12-31" id="ixv-320">COSMOS HEALTH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-12-31to2024-12-31" id="ixv-321">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2024-12-31to2024-12-31" id="ixv-322">000-54436</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-12-31to2024-12-31" id="ixv-323">27-0611758</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-12-31to2024-12-31" id="ixv-324">5 Agiou Georgiou</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-12-31to2024-12-31" id="ixv-325">Pilea</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-12-31to2024-12-31" id="ixv-326">Thessaloniki</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2024-12-31to2024-12-31" id="ixv-327">GR</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2024-12-31to2024-12-31" id="ixv-328">55438</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-12-31to2024-12-31" id="ixv-329">312</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-12-31to2024-12-31" id="ixv-330">865-0026</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2024-12-31to2024-12-31" id="ixv-331">Common Stock, $.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-12-31to2024-12-31" id="ixv-332">COSM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-12-31to2024-12-31" id="ixv-333">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="From2024-12-31to2024-12-31" id="ixv-334">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2024-12-31to2024-12-31" id="ixv-335">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2024-12-31to2024-12-31" id="ixv-336">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2024-12-31to2024-12-31" id="ixv-337">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-12-31to2024-12-31" id="ixv-338">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
